Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

TempraMed Technologies

Tracked across 2 events · 12 articles · First seen Sep 01, 2026 · Last active Sep 23, 2026

Sentiment
22
Attention
1
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 20
Business
Impact: TempraMed is the primary party, signing the LOI to expand into Greece. This supports its international growth strategy and could lead to increased sales, but the non-binding nature and pending definitive agreement temper immediate benefits.
Sep 01, 2026 · 6 articles
1 25
Business
TempraMed Technologies, a Canadian medical-device company trading on the CSE under VIVI, announced it entered into a distribution agreement dated August 25, 2026 with CenterWell Pharmacy, the pharmacy services brand of U.S. health insurer Humana…
Impact: TempraMed is the primary beneficiary of the distribution agreement, gaining access to CenterWell Pharmacy's U.S. distribution channel for its VIVI Cap and VIVI Epi products. The deal could support revenue growth, but the lack of minimum purchase commitments and easy termination keep the benefit uncertain.
Sep 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track TempraMed Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.